Akebia Therapeutics (AKBA) Other Operating Expenses (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Other Operating Expenses of $707000.0 for Q1 2026, up 0.86% year-over-year from $701000.0 in Q1 2025, and down 97.34% quarter-over-quarter from $26.6 million in Q4 2025.
Akebia Therapeutics (AKBA) Other Operating Expenses (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Other Operating Expenses for 11 consecutive years, with $707000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 0.86% year-over-year to $707000.0; the TTM figure through Mar 2026 stood at $29.0 million (up 804.98% YoY), while the FY2025 annual figure was $3.4 million, up 5.47% from the prior year.
- Other Operating Expenses eased to $707000.0 in Q1 2026 per AKBA's latest filing, from $26.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $26.6 million in Q4 2025 and bottomed at $449000.0 in Q1 2022.
- Historically, Other Operating Expenses has averaged $2.3 million across 5 years, with a median of $852000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 35.4% — and 2025, when it jumped 2614.83%.
- Akebia Therapeutics' Other Operating Expenses stood at $852000.0 in 2022, then advanced by 0.47% to $856000.0 in 2023, then rose by 14.25% to $978000.0 in 2024, then surged by 2614.83% to $26.6 million in 2025, then slumped by 97.34% to $707000.0 in 2026.
- Business Quant data shows AKBA's Other Operating Expenses at $707000.0 in Q1 2026, $26.6 million in Q4 2025, and $896000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Akebia Therapeutics | 240.51 Mn | 84.96 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 855,000.00 |
| Mar 31, 2026 | 707,000.00 |
| Dec 31, 2025 | 26.55 Mn |
| Sep 30, 2025 | 896,000.00 |
| Jun 30, 2025 | 896,000.00 |
| Mar 31, 2025 | 701,000.00 |
| Dec 31, 2024 | 978,000.00 |
| Sep 30, 2024 | 769,000.00 |
| Jun 30, 2024 | 762,000.00 |
| Mar 31, 2024 | 711,000.00 |
| Dec 31, 2023 | 856,000.00 |
| Sep 30, 2023 | 864,000.00 |
| Jun 30, 2023 | 949,000.00 |
| Mar 31, 2023 | 568,000.00 |
| Dec 31, 2022 | 852,000.00 |
| Sep 30, 2022 | 743,000.00 |
| Jun 30, 2022 | 892,000.00 |
| Mar 31, 2022 | 449,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 870,000.00 |